Year: - Any -2023202220212020201920182017 Items per page 102550 Date Title Jun 01, 2022 Summary ToggleSol-Gel Technologies to Participate in the 2022 Jefferies Global Healthcare Conference May 17, 2022 Summary ToggleSol-Gel Technologies to Present in Upcoming H.C. Wainwright Global Investment Conference May 13, 2022 Summary ToggleSol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update Apr 25, 2022 Summary ToggleSol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY® Apr 14, 2022 Summary ToggleSol-Gel Technologies Announces the Commercial Availability of TWYNEO® Mar 30, 2022 Summary ToggleSol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments Mar 25, 2022 Summary ToggleSol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA Dec 22, 2021 Summary ToggleSol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference Dec 21, 2021 Summary ToggleSol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY® Nov 11, 2021 Summary ToggleSol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Page 4 … Next page Next Last page Last
Year: - Any -2023202220212020201920182017 Items per page 102550 Date Title Jun 01, 2022 Summary ToggleSol-Gel Technologies to Participate in the 2022 Jefferies Global Healthcare Conference May 17, 2022 Summary ToggleSol-Gel Technologies to Present in Upcoming H.C. Wainwright Global Investment Conference May 13, 2022 Summary ToggleSol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update Apr 25, 2022 Summary ToggleSol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY® Apr 14, 2022 Summary ToggleSol-Gel Technologies Announces the Commercial Availability of TWYNEO® Mar 30, 2022 Summary ToggleSol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments Mar 25, 2022 Summary ToggleSol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA Dec 22, 2021 Summary ToggleSol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference Dec 21, 2021 Summary ToggleSol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY® Nov 11, 2021 Summary ToggleSol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Page 4 … Next page Next Last page Last